2026 AGENDA COMING SOON!
2025 Agenda – Friday, September 12^th

The Role of Drug Eluting Resorbable Scaffolds for Infrapopliteal CLTI
Moderator: Sahil A. Parikh, MD, FACC, FSCAI, Elizabeth A. Genovese, MD, MS, FACS, RPVI and Barbara Kind, Abbott Health Economics

SESSION IV | SUPERFICIAL FEMORAL ARTERY DISEASE: FEMOROPOPLITEAL PHASE 2

Session Head:

Bhaskar Purushottam, MD

Panel:

George S. Chrysant, MD Yann Gouëffic, MD, PhD Daniel K. Han, MD Steven Kum, MD Eric A. Secemsky, MD Peter A. Soukas, MD Jose M. Wiley, MD

1:50 pm

LIVE CASE PRESENTATION #4

Broadcast From: Ballad Health Holston Valley Medical Center, Kingsport, TN

Operator(s):

D. Christopher Metzger, MD

2:20 pm

Atherectomy Devices in Calcified Femoral-Popliteal Lesions

Lawrence A. Garcia, MD

2:30 pm

How I Cross Challenging Calcified SFA: Access, Technique, Wires and Devices

Yann Gouëffic, MD, PhD

2:40 pm

Does IVL Replace Atherectomy Devices in the Calcified SFA Disease?

Marianne Brodmann, MD

2:50 pm

Pave-and-Crack Technique: Role of Covered Stent in Calcified Lesions

Peter A. Soukas, MD

3:00 pm

Panel Discussion

SESSION V | SUPERFICIAL FEMORAL ARTERY DISEASE: FEMOROPOPLITEAL PHASE 3

Session Head:

Ajit G. Rao, MD

Panel:

Christian Bianchi, MD Fabrizio Fanelli, MD Lawrence A. Garcia, MD Nicolas Mouawad, MD Peter A. Soukas, MD

DEBATE 1

PTAB VS. PTFE BYPASS FOR CLAUDICATION

3:10 pm

Pro: PTFE Bypass is Still a Viable Option for Patients Who Have Failed Endovascular Therapy in Whom an Adequate Venous Conduit is Not Available

Christian Bianchi, MD

3:18 pm

Con: Endovascular Intervention and Advent of PTAB Make PTFE Bypass Obsolete

Peter A. Soukas, MD

DEBATE 2

3:26 pm

DES is Superior to DCB in Long-Segment Disease

Eric A. Secemsky, MD

3:34 pm

DCB with Spot Stenting is the Right Way to Treat Long-Segment SFA Disease

Fabrizio Fanelli, MD

3:42 pm

BREAK / VISIT EXHIBITS

SESSION VI | SUPERFICIAL FEMORAL ARTERY DISEASE: FEMOROPOPLITEAL PHASE 4

Session Head:

Raman Sharma, MD

Panel:

Anvar Babaev, MD, PhD Tatsuya Nakama, MD Ajit G. Rao, MD Jose M. Wiley, MD

3:52 pm

LIVE CASE PRESENTATION #5

Broadcast From: Cardiovascular Institute of the South, Houma, LA

Operator(s):

Pradeep K. Nair, MD

4:22 pm

Choice of Atherectomy Device in ISR: How Do I Choose?

Nicolas Mouawad, MD

4:32 pm

DCB or DES in ISR: Is There Data to Suggest One Over the Other?

Tatsuya Nakama, MD

4:42 pm

Role of Thrombectomy Devices and Filters in ISR

Jose M. Wiley, MD

4:52 pm

PTAB vs. Covered Stent in ISR: Where Do They Fit in the Algorithm?

Peter A. Soukas, MD

5:02 pm

Panel Discussion / Q&A

5:12 pm

Closing Remarks

Prakash Krishnan, MD

5:20 pm

CME SESSION ENDS

5:30 pm -
6:30 pm

EVENING RECEPTION | 5^th Floor – Salon 1 ~ Supported by Endologix

Advancing SFA Revascularization: Clinical Experience with Percutaneous Bypass using DETOUR
Ajit G. Rao, MD and David D. Song, MD

To obtain additional details on Exhibiting at NYEVS 2026, please contact
Trinity Campbell, Gaffney Events | 425.354.8937 | [email protected]

2026 AGENDA COMING SOON! 2025 Agenda – Friday, September 12th

LOCATION: New York Marriott Marquis, 5th Floor Ballroom

Registration / Continental Breakfast

Welcome and Introduction

KEYNOTE LECTURE: My Journey from Clinician/Scientist to Inventor and Entrepreneur

LIVE CASE PRESENTATION #1

Iliac CTOs: Access, Tools, and Crossing Technique / Re-entry

Therapy of Choice for Different Lesion Characteristics: Case Examples and My Algorithm

How I Treat the Distal Aorto-Iliac Disease

Complex Case Presentation and Discussion / Polling Questions

BREAK / VISIT EXHIBITS

LIVE CASE PRESENTATION #2

Debate: Endovascular Intervention vs. Surgical Endarterectomy for Common Femoral Disease: The Great Debate

Concomitant CFA and Iliac or SFA Disease: Should I Treat Both? – Hybrid vs. Endo; Does it Matter?

Different CFA Case Types with Voting

Panel Discussion

LIVE CASE PRESENTATION #3

What is Vessel Prep and Do I Need it Prior to Therapy?

Role of IVUS in Evaluation and Assessment of Lesion Morphology: Does It Dictate Type of Vessel Prep and Destination Therapy?

Therapy of Choice for Long-Segment SFA Disease: DCB vs. DES vs. Supera vs. Spot Stenting

My Algorithm to Treat the Heavily Calcified SFA Stenosis

What’s On the Horizon for the Fem-Pop Segment?

ADJOURN CME SESSION / PICK UP LUNCH / VISIT EXHIBITS

LUNCH SYMPOSIUM – Supported by Abbott, not CME Accredited

LIVE CASE PRESENTATION #4

Atherectomy Devices in Calcified Femoral-Popliteal Lesions

How I Cross Challenging Calcified SFA: Access, Technique, Wires and Devices

Does IVL Replace Atherectomy Devices in the Calcified SFA Disease?

Pave-and-Crack Technique: Role of Covered Stent in Calcified Lesions

Panel Discussion

PTAB VS. PTFE BYPASS FOR CLAUDICATION

Pro: PTFE Bypass is Still a Viable Option for Patients Who Have Failed Endovascular Therapy in Whom an Adequate Venous Conduit is Not Available

Con: Endovascular Intervention and Advent of PTAB Make PTFE Bypass Obsolete

DES is Superior to DCB in Long-Segment Disease

DCB with Spot Stenting is the Right Way to Treat Long-Segment SFA Disease

BREAK / VISIT EXHIBITS

LIVE CASE PRESENTATION #5

Choice of Atherectomy Device in ISR: How Do I Choose?

DCB or DES in ISR: Is There Data to Suggest One Over the Other?

Role of Thrombectomy Devices and Filters in ISR

PTAB vs. Covered Stent in ISR: Where Do They Fit in the Algorithm?

Panel Discussion / Q&A

Closing Remarks

CME SESSION ENDS

EVENING RECEPTION | 5th Floor – Salon 1 ~ Supported by Endologix

Available June 16th!

Coming Soon

Coming Soon

Coming Soon

Coming Soon

Coming Soon

Coming Soon

Coming Soon

Coming Soon

2026 AGENDA COMING SOON!
2025 Agenda – Friday, September 12^th

LOCATION: New York Marriott Marquis, 5^th Floor Ballroom

EVENING RECEPTION | 5^th Floor – Salon 1 ~ Supported by Endologix

Available
June 16^th!